Codexis (CDXS)
(Delayed Data from NSDQ)
$2.91 USD
+0.02 (0.69%)
Updated Sep 25, 2024 03:59 PM ET
After-Market: $2.92 +0.01 (0.34%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth A Momentum F VGM
Codexis (CDXS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$6.86 | $11.00 | $3.00 | 137.37% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Codexis comes to $6.86. The forecasts range from a low of $3.00 to a high of $11.00. The average price target represents an increase of 137.37% from the last closing price of $2.89.
Analyst Price Targets (7 )
Broker Rating
Codexis currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.50 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, six are Strong Buy, representing 75% of all recommendations. A month ago, Strong Buy represented 75%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 7 | 7 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.50 | 1.50 | 1.50 | 1.25 | 1.25 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/29/2024 | Cantor Fitzgerald & Co | Kristen Kluska | Strong Buy | Strong Buy |
8/23/2024 | Cowen & Co. | Brendan Smith | Not Available | Hold |
8/19/2024 | The Benchmark Company | Robert Wasserman | Strong Buy | Hold |
8/15/2024 | Piper Sandler | Allison M Bratzel | Strong Buy | Strong Buy |
8/9/2024 | Craig-Hallum | Matthew G Hewitt | Strong Buy | Strong Buy |
8/9/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/3/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
6/3/2024 | Stephens | Jacob Johnson | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.50 |
ABR (Last week) | 1.50 |
# of Recs in ABR | 8 |
Average Target Price | $6.86 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 82 of 253 |
Current Quarter EPS Est: | -0.25 |
CDXS FAQs
Codexis, Inc. (CDXS) currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 8 brokerage firms.
The average price target for Codexis, Inc. (CDXS) is $6.86. The current on short-term price targets is based on 5 reports.
The forecasts for Codexis, Inc. (CDXS) range from a low of $3 to a high of $11. The average price target represents a increase of $137.37 from the last closing price of $2.89.
The current UPSIDE for Codexis, Inc. (CDXS) is 137.37%
Based on short-term price targets offered by seven analysts, the average price target for Codexis comes to $6.86. The forecasts range from a low of $3.00 to a high of $11.00. The average price target represents an increase of 137.37% from the last closing price of $2.89.